A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Public ClinicalTrials.gov record NCT01877915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effectiveness and safety of rivaroxaban compared with placebo (inactive medication), in reducing the risk of death, myocardial infarction or stroke in participants with heart failure and significant coronary artery disease following an episode of decompensated heart failure.
Study identification
- NCT ID
- NCT01877915
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 5,081 participants
Conditions and interventions
Conditions
Interventions
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2013 (Actual)
- Primary completion
- Apr 19, 2018 (Actual)
- Completion
- Apr 19, 2018 (Actual)
- Last update posted
- May 10, 2019
2013 – 2018
United States locations
- U.S. sites
- 115
- U.S. states
- 37
- U.S. cities
- 115
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alexander City | Alabama | — | — |
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Anchorage | Alaska | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Newport Beach | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Stockton | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Atlantis | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Wellington | Florida | — | — |
| Not listed | Winter Haven | Florida | — | — |
| Not listed | Athens | Georgia | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Cumming | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Tucker | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Fairview Heights | Illinois | — | — |
| Not listed | Peoria | Illinois | — | — |
| Not listed | Rockford | Illinois | — | — |
| Not listed | Urbana | Illinois | — | — |
| Not listed | Anderson | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Merrillville | Indiana | — | — |
| Not listed | Munster | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Elizabethtown | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Bossier City | Louisiana | — | — |
| Not listed | Hammond | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Slidell | Louisiana | — | — |
| Not listed | Biddeford | Maine | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Columbia | Maryland | — | — |
| Not listed | Randallstown | Maryland | — | — |
| Not listed | Bay City | Michigan | — | — |
| Not listed | Grand Blanc | Michigan | — | — |
| Not listed | Mount Clemens | Michigan | — | — |
| Not listed | Pontiac | Michigan | — | — |
| Not listed | Ypsilanti | Michigan | — | — |
| Not listed | Saint Paul | Minnesota | — | — |
| Not listed | Springfield | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Washington | Missouri | — | — |
| Not listed | Lincoln | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Bridgewater | New Jersey | — | — |
| Not listed | Elmer | New Jersey | — | — |
| Not listed | Haddon Heights | New Jersey | — | — |
| Not listed | Manalapan | New Jersey | — | — |
| Not listed | Ridgewood | New Jersey | — | — |
| Not listed | Sewell | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Cortlandt Manor | New York | — | — |
| Not listed | Jamaica | New York | — | — |
| Not listed | Mineola | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Pinehurst | North Carolina | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Fairfield | Ohio | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Bartlesville | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Sayre | Pennsylvania | — | — |
| Not listed | Sellersville | Pennsylvania | — | — |
| Not listed | Wynnewood | Pennsylvania | — | — |
| Not listed | Yardley | Pennsylvania | — | — |
| Not listed | York | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Sioux Falls | South Dakota | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Cypress | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Huntsville | Texas | — | — |
| Not listed | Kingwood | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | McKinney | Texas | — | — |
| Not listed | Burlington | Vermont | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Bellingham | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
| Not listed | Huntington | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 447 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01877915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01877915 live on ClinicalTrials.gov.